What does CUSIP 253748305 represent in this 13F holders report?

CUSIP 253748305 is the security identifier for 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR used to aggregate holder disclosures.

How many institutions held 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in Q4 2018?

10 institutional investors reported 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR for Q4 2018. Use the holders table for investor-level position and value details.

DIFFUSION PHARMACEUTICALS IN - COM PAR

CUSIP: 253748305

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / COM PAR
Total 13F shares: 210,014
Share change: +210,014
Total reported value: $417,000
Price per share: $1.99
Number of holders: 10
Value change: +$417,000
Number of buys: 10

Quarterly Holders Quick Answers

What is CUSIP 253748305?
CUSIP 253748305 identifies 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019

Recent filing periods for CUSIP 253748305:

Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM PAR as of Q4 2018

As of 31 Dec 2018, DIFFUSION PHARMACEUTICALS IN - COM PAR was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 210,014 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, Anson Funds Management LP, TWO SIGMA INVESTMENTS, LP, Virtu Financial LLC, Swift Run Capital Management, LLC, CITADEL ADVISORS LLC, UBS Group AG, PNC Financial Services Group, Inc., and CITIGROUP INC. This page lists 10 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.